Resveratrol promotes degradation of the human bile acid transporter ASBT (SLC10A2)

Biochemical Journal

Volumn 459, Issue 2, 2014, Pages 301-312

  Chothe, Paresh P ^a   Swaan, Peter W ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

Apical sodium dependent bile acid transporter (ASBT); Cholesterol; Degradation; Proteasome; Resveratrol; Ubiquitination

Indexed keywords

APICAL SODIUM DEPENDENT BILE ACID TRANSPORTER; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CARRIER PROTEINS AND BINDING PROTEINS; CHOLESTEROL; LACTACYSTIN; LDN 57444; PROTEASOME; PROTEIN INHIBITOR; RESVERATROL; SERINE; SIRTUIN 1; THREONINE; UBIQUITIN; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN CACO 2; CHOLESTEROL LOWERING EFFECT; CONTROLLED STUDY; DRUG EFFECT; EMBRYO; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; REGULATORY MECHANISM;

ANIMALS; CELL LINE; GENE EXPRESSION REGULATION; HUMANS; ORGANIC ANION TRANSPORTERS, SODIUM-DEPENDENT; PHOSPHORYLATION; PROTEIN TRANSPORT; PROTEOLYSIS; SIRTUIN 1; STILBENES; SYMPORTERS;

EID: 84897553329     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20131428     Document Type: Article

References (44)

1. Shneider, B. L. (2001) Intestinal bile acid transport: biology, physiology, and pathophysiology. J. Pediatr. Gastroenterol. Nutr. 32, 407-417
2. Dawson, P. A. (2011) Role of the intestinal bile acid transporters in bile acid and drug disposition. Handb. Exp. Pharmacol. 201, 169-203
3. Kosters, A. and Karpen, S. J. (2008) Bile acid transporters in health and disease. Xenobiotica 38, 1043-1071
4. Hofmann, A. F. and Hagey, L. R. (2008) Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics. Cell. Mol. Life Sci. 65, 2461-2483
5. +-dependent bile acid transporter reduces serum cholesterol levels in hamsters and monkeys. Eur. J. Pharmacol. 539, 89-98
6. West, K. L., Zern, T. L., Butteiger, D. N., Keller, B. T. and Fernandez, M. L. (2003) SC-435, an ileal apical sodium co-dependent bile acid transporter (ASBT) inhibitor lowers plasma cholesterol and reduces atherosclerosis in guinea pigs. Atherosclerosis 171, 201-210 (Pubitemid 37492881)
7. West, K. L., McGrane, M., Odom, D., Keller, B. and Fernandez, M. L. (2005) SC-435, an ileal apical sodium-codependent bile acid transporter inhibitor alters mRNA levels and enzyme activities of selected genes involved in hepatic cholesterol and lipoprotein metabolism in guinea pigs. J. Nutr. Biochem. 16, 722-728 (Pubitemid 41630606)
8. Shih, D. Q., Bussen, M., Sehayek, E., Ananthanarayanan, M., Shneider, B. L., Suchy, F. J., Shefer, S., Bollileni, J. S., Gonzalez, F. J., Breslow, J. L. and Stoffel, M. (2001) Hepatocyte nuclear factor-1α is an essential regulator of bile acid and plasma cholesterol metabolism. Nat. Genet. 27, 375-382 (Pubitemid 32268417)
9. Jung, D., Fried, M. and Kullak-Ublick, G. A. (2002) Human apical sodium-dependent bile salt transporter gene (SLC10A2) is regulated by the peroxisome proliferator-activated receptor α. J. Biol. Chem. 277, 30559-30566 (Pubitemid 34970749)
10. Jung, D., Fantin, A. C., Scheurer, U., Fried, M. and Kullak-Ublick, G. A. (2004) Human ileal bile acid transporter gene ASBT (SLC10A2) is transactivated by the glucocorticoid receptor. Gut 53, 78-84 (Pubitemid 38083014)
11. Alrefai, W. A. and Gill, R. K. (2007) Bile acid transporters: structure, function, regulation and pathophysiological implications. Pharm. Res. 24, 1803-1823 (Pubitemid 47389235)
12. Chawla, A., Repa, J. J., Evans, R. M. and Mangelsdorf, D. J. (2001) Nuclear receptors and lipid physiology: opening the X-files. Science 294, 1866-1870 (Pubitemid 33101573)
13. Neimark, E., Chen, F., Li, X. and Shneider, B. L. (2004) Bile acid-induced negative feedback regulation of the human ileal bile acid transporter. Hepatology 40, 149-156 (Pubitemid 38877576)
14. Neimark, E., Chen, F., Li, X., Magid, M. S., Alasio, T. M., Frankenberg, T., Sinha, J., Dawson, P. A. and Shneider, B. L. (2006) c-Fos is a critical mediator of inflammatory-mediated repression of the apical sodium-dependent bile acid transporter. Gastroenterology 131, 554-567 (Pubitemid 44142447)
15. Xia, X., Roundtree, M., Merikhi, A., Lu, X., Shentu, S. and Lesage, G. (2004) Degradation of the apical sodium-dependent bile acid transporter by the ubiquitin-proteasome pathway in cholangiocytes. J. Biol. Chem. 279, 44931-44937 (Pubitemid 39430906)
16. Bertelli, A. A. and Das, D. K. (2009) Grapes, wines, resveratrol, and heart health. J. Caridiovasc. Pharmacol. 54, 468-476
17. Das, D. K., Mukherjee, S. and Ray, D. (2011) Erratum to: resveratrol and red wine, healthy heart and longevity. Heart Fail. Rev. 16, 425-435
18. Chen, Q., Wang, E., Ma, L. and Zhai, P. (2012) Dietary resveratrol increases the expression of hepatic 7α-hydroxylase and ameliorates hypercholesterolemia in high-fat fed C57BL/6J mice. Lipids Health Dis. 11, 56
19. Do, G. M., Kwon, E. Y., Kim, H. J., Jeon, S. M., Ha, T. Y., Park, T. and Choi, M. S. (2008) Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice. Biochem. Biophys. Res. Commun. 374, 55-59
20. Rimando, A. M., Nagmani, R., Feller, D. R. and Yokoyama, W. (2005) Pterostilbene, a new agonist for the peroxisome proliferator-activated receptor α-isoform, lowers plasma lipoproteins and cholesterol in hypercholesterolemic hamsters. J. Agric. Food Chem. 53, 3403-3407 (Pubitemid 40758174)
21. Castilla, P., Echarri, R., Davalos, A., Cerrato, F., Ortega, H., Teruel, J. L., Lucas, M. F., Gómez-Coronado, D., Ortuño, J. and Lasunción, M. A. (2006) Concentrated red grape juice exerts antioxidant, hypolipidemic, and antiinflammatory effects in both hemodialysis patients and healthy subjects. Am. J. Clin. Nutr. 84, 252-262 (Pubitemid 44699192)
22. Walle, T., Hsieh, F., DeLegge, M. H., Oatis, Jr, J. E. and Walle, U. K. (2004) High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab. Dispos. 32, 1377-1382 (Pubitemid 39564557)
23. Alrefai, W. A., Sarwar, Z., Tyagi, S., Saksena, S., Dudeja, P. K. and Gill, R. K. (2005) Cholesterol modulates human intestinal sodium-dependent bile acid transporter. Am. J. Physiol. Gastrointest. Liver Physiol. 288, G978-G985 (Pubitemid 40563140)
24. Annaba, F., Sarwar, Z., Kumar, P., Saksena, S., Turner, J. R., Dudeja, P. K., Gill, R. K. and Alrefai, W. A. (2008) Modulation of ileal bile acid transporter (ASBT) activity by depletion of plasma membrane cholesterol: association with lipid rafts. Am. J. Physiol. Gastrointest. Liver Physiol. 294, G489-G497 (Pubitemid 351253334)
25. da Silva, T. C., Hussainzada, N., Khantwal, C. M., Polli, J. E. and Swaan, P. W. (2011) Transmembrane helix 1 contributes to substrate translocation and protein stability of bile acid transporter SLC10A2. J. Biol. Chem. 286, 27322-27332
26. Craddock, A. L., Love, M. W., Daniel, R. W., Kirby, L. C., Walters, H. C., Wong, M. H. and Dawson, P. A. (1998) Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter. Am. J. Physiol. 274, G157-G169
27. Yeung, Y. G. and Stanley, E. R. (2009) A solution for stripping antibodies from polyvinylidene fluoride immunoblots for multiple reprobing. Anal. Biochem. 389, 89-91
28. Ballatori, N., Christian, W. V., Lee, J. Y., Dawson, P. A., Soroka, C. J., Boyer, J. L., Madejczyk, M. S. and Li, N. (2005) OSTα-OSTβ: a major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia. Hepatology 42, 1270-1279 (Pubitemid 43260029)
29. Sevov, M., Elfineh, L. and Cavelier, L. B. (2006) Resveratrol regulates the expression of LXR-α in human macrophages. Biochem. Biophys. Res. Commun. 348, 1047-1054 (Pubitemid 44233521)
30. de Athayde Moncorvo Collado, A., Corbalan, N., Homolya, L., Morero, R. and Minahk, C. (2013) Resveratrol modulates ATPase activity of liposome-reconstituted ABCG1. FEBS Lett. 587, 2359-2363
31. Elangovan, S., Ramachandran, S., Venkatesan, N., Ananth, S., Gnana-Prakasam, J. P., Martin, P. M., Browning, D. D., Schoenlein, P. V., Prasad, P. D., Ganapathy, V. and Thangaraju, M. (2011) SIRT1 is essential for oncogenic signaling by estrogen/estrogen receptor α in breast cancer. Cancer Res. 71, 6654-6664
32. Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K. et al. (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337-342 (Pubitemid 44764104)
33. Marambaud, P., Zhao, H. and Davies, P. (2005) Resveratrol promotes clearance of Alzheimer's disease amyloid-β peptides. J. Biol. Chem. 280, 37377-37382 (Pubitemid 41642343)
34. Cao, Z., Fang, J., Xia, C., Shi, X. and Jiang, B. H. (2004) Trans-3,4,5′-trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells. Clin. Cancer Res. 10, 5253-5263 (Pubitemid 39099800)
35. Joe, A. K., Liu, H., Suzui, M., Vural, M. E., Xiao, D. and Weinstein, I. B. (2002) Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin. Cancer Res. 8, 893-903 (Pubitemid 34742123)
36. Pozo-Guisado, E., Lorenzo-Benayas, M. J. and Fernandez-Salguero, P. M. (2004) Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor α-dependent mechanism: relevance in cell proliferation. Int. J. Cancer 109, 167-173 (Pubitemid 38240916)
37. Farghali, H., Kutinova Canova, N. and Lekic, N. (2013) Resveratrol and related compounds as antioxidants with an allosteric mechanism of action in epigenetic drug targets. Physiol. Res. 62, 1-13
38. Arichi, H., Kimura, Y., Okuda, H., Baba, K., Kozawa, M. and Arichi, S. (1982) Effects of stilbene components of the roots of Polygonum cuspidatum Sieb. et Zucc. on lipid metabolism. Chem. Pharm. Bull. 30, 1766-1770 (Pubitemid 12029652)
39. Zern, T. L., Wood, R. J., Greene, C., West, K. L., Liu, Y., Aggarwal, D., Shachter, N. S. and Fernandez, M. L. (2005) Grape polyphenols exert a cardioprotective effect in pre- and postmenopausal women by lowering plasma lipids and reducing oxidative stress. J. Nutr. 135, 1911-1917 (Pubitemid 41099749)
40. Kaldas, M. I., Walle, U. K. and Walle, T. (2003) Resveratrol transport and metabolism by human intestinal Caco-2 cells. J. Pharm. Pharmacol. 55, 307-312 (Pubitemid 36410351)
41. -/- mice. Atherosclerosis 229, 374-380
42. Kuhlkamp, T., Keitel, V., Helmer, A., Haussinger, D. and Kubitz, R. (2005) Degradation of the sodium taurocholate cotransporting polypeptide (NTCP) by the ubiquitin-proteasome system. Biol. Chem. 386, 1065-1074 (Pubitemid 41548738)
43. Kemper, J. K., Xiao, Z., Ponugoti, B., Miao, J., Fang, S., Kanamaluru, D., Tsang, S., Wu, S. Y., Chiang, C. M. and Veenstra, T. D. (2009) FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states. Cell Metab. 10, 392-404
44. Floyd, Z. E., Wang, Z. Q., Kilroy, G. and Cefalu, W. T. (2008) Modulation of peroxisome proliferator-activated receptor γ stability and transcriptional activity in adipocytes by resveratrol. Metabolism 57, S32-S38 (Pubitemid 351814704)